Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Caredx Inc

Start price
Target price
Perf. (%)
€30.31
19.08.24
€40.00
31.10.26
-17.55%
04.09.24

Could be very worthwhile Investment >20% year
BiotechBee 
19.08.24 70%
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.50
18.08.24
-
18.08.25
-12.06%
30.08.24

Could be very worthwhile Investment >20% year
Vassago1 
18.08.24 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€2.91
18.08.24
-
18.08.25
7.14%
30.08.24

Could be worthwhile Investment >10% per year
Vassago1 
18.08.24 50%
sell
Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.21
18.08.24
-
18.08.25
-
15.07.23

StockNews.com 
18.08.24 50%
sell
Glycomimetics Inc.

Start price
Target price
Perf. (%)
€0.16
18.08.24
-
18.08.25
-10.00%
04.09.24

StockNews.com 
18.08.24 50%
buy
Sanofi S.A. ADR

Start price
Target price
Perf. (%)
€48.80
18.08.24
-
18.08.25
6.56%
04.09.24

StockNews.com 
18.08.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1,072.5
17.08.24
-
17.08.25
-1.35%
08:06

StockNews.com 
17.08.24 50%
sell
Cara Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.26
17.08.24
-
17.08.25
11.86%
03.09.24

StockNews.com 
17.08.24 50%
sell
Tonix Pharmaceuticals Holding Corp.

Start price
Target price
Perf. (%)
€2.82
17.08.24
-
17.08.25
-
09.02.24

StockNews.com 
17.08.24 50%
sell
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.41
17.08.24
-
17.08.25
-
21.03.24

StockNews.com 
17.08.24 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.07
17.08.24
-
17.08.25
10.34%
31.08.24

Could be very worthwhile Investment >20% year
blaugold 
17.08.24 50%
sell
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.63
17.08.24
-
17.08.25
3.87%
03.09.24

Revenue decline/stagnation expected
Risky Investment
Lokrim 
17.08.24 20%
buy
Valneva SE

Start price
Target price
Perf. (%)
€3.44
17.08.24
€14.00
17.09.24
-6.98%
08:11

Undervalued
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
ROKOBA 
17.08.24 90%
buy
Arca Biopharma

Start price
Target price
Perf. (%)
€2.86
17.08.24
-
17.08.25
77.19%
31.08.24

Could be worthwhile Investment >10% per year
melinda 
17.08.24 10%
buy
Personalis Inc

Start price
Target price
Perf. (%)
€5.28
16.08.24
€6.35
16.08.25
-7.91%
04.09.24

BTIG Research 
16.08.24 50%
buy
Personalis Inc

Start price
Target price
Perf. (%)
€5.44
16.08.24
€6.58
16.08.25
-10.62%
04.09.24

Needham & Company LLC 
16.08.24 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€844.20
16.08.24
€935.65
16.08.25
1.15%
08:06

Guggenheim 
16.08.24 50%
buy
Sutro Biopharma Inc

Start price
Target price
Perf. (%)
€3.88
16.08.24
€13.63
16.08.25
0.00%
04.09.24

Truist Financial Co. 
16.08.24 50%
buy
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€10.33
16.08.24
€7.28
16.08.25
-34.19%
08:05

Benchmark Co. 
16.08.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€240.00
16.08.24
€336.33
16.08.25
-4.79%
04.09.24

The Goldman Sachs Group, Inc. 
16.08.24 50%
buy
Amicus Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.40
16.08.24
€14.55
16.08.25
0.96%
04.09.24

JPMorgan Chase & Co. 
16.08.24 50%
buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€0.65
15.08.24
€2.73
15.08.25
-21.70%
04.09.24

Bank of America Co. 
15.08.24 50%
buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€0.70
15.08.24
€3.64
15.08.25
-27.78%
04.09.24

Barclays PLC 
15.08.24 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€2.99
15.08.24
€12.75
15.08.25
-0.94%
03.09.24

Citigroup Inc. 
15.08.24 50%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€0.48
15.08.24
€3.65
15.08.25
-14.56%
03.09.24

HC Wainwright 
15.08.24 50%